- High Expression of Ribonucleotide Reductase Subunit M2 Correlates with Poor Prognosis of Hepatocellular Carcinoma
-
Lee B, Ha SY, Song DH, Lee HW, Cho SY, Park CK
- KMID: 2070085
- Gut Liver.
- 2014 Nov;8(6):662-668.
- doi: 10.5009/gnl13392
BACKGROUND/AIMS: Ribonucleotide reductase subunit M2 (RRM2) catalyzes the production of deoxynucleotide triphosphates, which are necessary for DNA synthesis. RRM2 has been reported to play an active role in tumor progression,... -
- CITED
-
- Close
- SHARE
-
- Close
- High Expression of Aldo-Keto Reductase 1B10 Is an Independent Predictor of Favorable Prognosis in Patients with Hepatocellular Carcinoma
-
Ha SY, Song DH, Lee JJ, Lee HW, Cho SY, Park CK
- KMID: 2070083
- Gut Liver.
- 2014 Nov;8(6):648-654.
- doi: 10.5009/gnl13406
BACKGROUND/AIMS: Upregulation of aldo-keto reductase 1B10 (AKR1B10) through the mitogenic activator protein-1 signaling pathway might promote hepatocarcinogenesis and tumor progression. The goal of this study was to evaluate the prognostic... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Significance of p53, mTOR, c-Met, IGF-1R, and HSP70 Overexpression after the Resection of Hepatocellular Carcinoma
-
Kang GH, Lee BS, Lee ES, Kim SH, Lee HY, Kang DY
- KMID: 1774532
- Gut Liver.
- 2014 Jan;8(1):79-87.
BACKGROUND/AIMS: The current study examines the expression of molecular biomarkers in hepatocellular carcinoma (HCC) and whether these findings correlate with the clinicopathologic features of the disease and patient survival. METHODS: We... -
- CITED
-
- Close
- SHARE
-
- Close
